the bird model illinois scienceillinois science to chicago... · the bird model illinois...
TRANSCRIPT
Building U.S.-IsraelLif S i P t hiLife Sciences Partnerships
Illinois ScienceThe BIRD Model Illinois Science&
Technology Park
Chicago
March 15, 2012
Dr. Eitan YudilevichExecutive DirectorBIRD F d i
11
BIRD Foundation
BIRD Foundation
Joint fund, established in 1977 as a joint initiative
BIRD = Binational Industrial Research and Development
, jbetween the US and Israeli governments
Mission FundingTo stimulate, promote and support joint (non-defense)
industrial R&D of mutual
Income from interest earned on $110 million endowment grant and from repayments
g
industrial R&D of mutual benefit to Israel and the
United States
grant and from repayments from successful BIRD
projects
22
BIRD’s Approach in a Nutshell BIRD helps in finding strategic partners (“matchmaking”)
BIRD ff diti l t f j i t d l t
pp
BIRD offers conditional grants for joint development on a risk sharing basis (private sector cost-share)
BIRD funds up to 50% of each company’s R&D expensesBIRD funds up to 50% of each company s R&D expenses associated with the joint project
BIRD claims repayments as royalties only if commercial revenues are generated from the project (repayments: up to 150% of the original conditional grant, CPI adjusted)
As an example of mutual benefit: U S company benefitsAs an example of mutual benefit: U.S. company benefits from access to innovation and IP; Israeli company benefits from complementary required capabilities and market access (other combinations are possible e gaccess (other combinations are possible, e.g., complementary technologies)
March 201233
BIRD – Performance Summaryy
$295M granted
845 projectsp japproved
$94M repaymentsfrom projects
~$8B i l~$8B in sales generated directly and indirectly by BIRD sponsored activities
March 201244
Repayments Schedule(Based on Revenue)(Based on Revenue)
Years from % of the grant Project
Completionto be repaid
Maximum repayment obligation: 150%
1 100%
Repayment rate: 5% of2 113%
3 125%
Repayment rate: 5% of Sales
Semiannual repayments4 138%
5 & Be ond 150%
Semiannual repayments, indexed to CPI-U
5 & Beyond 150%
March 20126
Submitting Process (two cycles per year)** For the exact dates of the upcoming cycle see www birdf com
Executive Summaries March SeptemberCycle I Cycle II
For the exact dates of the upcoming cycle see www.birdf.com
Executive Summaries
Final Proposal
Proposal Evaluation
March September
April October
Proposal EvaluationEvaluators appointed by NIST
& the Chief Scientist’s Office
DecisionsAt the Board of Governors’Meeting
June December
Company to Company Agreement
Cooperation and Project Funding AgreementMarch 20127
Once Project is Awarded…
Company to Company Agreementp y p y g
Financial Due Diligence
Cooperation and Project Funding AgreementCooperation and Project Funding Agreement
Project performance
Every 6 months:Financial &
End of project: Auditperformance a c a &
Milestone Reports Sales report
8 March 2012
BIRD Approved Projects by Industry2006 20112006- 2011
Communications15%Cleantech
18%
Others
HLS6%
4%
Life Sciences29%
Software
Healthcare IT4%
Electronics15%
Software9%
March 201299 Total # of Projects = 144, including “BIRD Energy” (13 projects)
Examples of projects approved in 2011Israeli
CompanyUS
CompanyProject Area
ARTART Healthcare
Hydrofera Anti pulmonary aspiration seal Medical Devices
BioMarCareTechnologies
AriadneDiagnostic test for metastatic colorectal cancer
Life SciencesTechnologies colorectal cancer
Healarium The Mayo ClinicApplication for self monitoring of cardiovascular risk
Healthcare IT
Semantic Medical Simulations –SMS
Sitel/MedStar Health
Semantic medical simulation platform Healthcare IT
AGM Tonson EndoStimMiniaturization of an implantablemedical device for GERD
Medical Devices
MedCPU Cleveland ClinicCare Pathway Decision Support
Healthcare IT
March 20121010
MedCPU Cleveland ClinicProject
Healthcare IT
Semantipedia Daylight CIS Semantic Web for Life Sciences Healthcare IT
Examples of BIRD Awardees Israeli CompaniesIsraeli Companies
MITAM
E t hExotechBio Solutions
March 201211
Examples of BIRD AwardeesIsraeli Companies - continuedIsraeli Companies continued
Bet Shemesh Engines
March 201214
BIRD AwardeesExamples of US Companies - continuedExamples of US Companies - continued
March 20121717
Medical Devices
CByond specialized in designing video-scopes for
Project title:
Fox Electronic Video Cameradesigning video scopes for medical applications.
ACMI (American Cystoscope Makers, Inc.; Now: Gyrus ACMI, an Olympus company), is a leader in the development and production of the world’s finest endoscopy
Joint development product:Flexible endoscope with integrated miniature video camera and LED as a li ht
March 201222
world s finest endoscopy instrumentation for the medical industry.
light source.
Slide Approved by Companies or Information is Public Domain22
Medical Instrumentation
Argo Medical invented the external wearable skeleton enabling the
Project title: ReWalk – Clinical Trials at MossRehab (Philadelphia)
walking of paraplegic patients.
Allied Orthotics & ProstheticsJoint development product: ReWalk is a motorized exoskeleton suit that enablesAllied Orthotics & Prosthetics
business is the design, custom-manufacturing, fitting, training of a complete range of orthotic and
th ti d t f di bl d
motorized exoskeleton suit that enables patients with lower limb disabilities, including complete paralysis, to independently engage in ambulatory activities, including standing, walking and in some cases climbing stairs.
prosthetic products for disabled people.
g g
Slide Approved by Companies or Information is Public Domain23 June 2010
g5ZY1a8http://www.youtube.com/watch?v=IaiO
Life Sciences - Pharma
Bio-Technology General Ltd. had extensive expertise in production and
f f
Project title: Development of PEG-Uricase for Treatment of Intractable Gout and Related Conditions
purification of recombinant proteins for parenteral use (acquired by Savient Pharmaceuticals Inc.)
Mountain ViewJoint development product: Development of
ff ti th f ti t ithMountain View Pharmaceuticals, Inc.experts in protein chemistry and the synthesis of PEG
effective therapy for patients with severe and presently untreatable gout. The drug is called Krystexxa, marketed by Savient
March 201224
derivatives.y
Pharmaceuticals
Healthcare/Orthodontics
Project title: 3D Imaging for
Cadent develops and sells proprietary 3D-based services to
Project title: 3D Imaging for Orthodontics (Presently marketed by Cadent only)
dental officesNote: Cadent established a significant U.S. operation as well (NJ)
3M U it k d i f tJoint development product:
(NJ)
3M Unitek designs, manufactures and sells of orthodontic appliances, and it is the world’s largest supplier of these products (Acquired by 3M in
Computer-guided bracket placement system that calculates optimal bracket placement positions, saving time, reducing errors and increasing treatment
Slide Approved by Companies or Information is Public Domain26 March 2012
p ( q y1987) efficiency
Software/Healthcare
P j t titl
Aliroo Ltd. is an international developer of innovative enterprise I f ti d I t t S it
Project title:Advance Secure eMail System ("ASES”)
Information and Internet Security solutions.
Eastman Kodak: Kodak's Health
Joint Development product: Secure E-Mail Service for healthcare services, which can encrypt e-mail messages and theirEastman Kodak: Kodak's Health
Imaging Group is a world leader in developing, manufacturing and marketing intelligent imaging products from analog to digital (in 2007 became Carestream Health)
encrypt e-mail messages and their attachments so that patient information and images can be sent securely over the Internet to physicians, patients and other healthcare providers.
27
digital (in 2007 became Carestream Health)
Slide Approved by Companies or Information is Public Domain
Food Technology
Fresh-Point is a private company specializes in the area of smart
Project title: Novel Time Temperature Indicators.
packaging, such as novel organic crystal-based time-temperature indicator
Ciba Specialty Chemicals Corp is aFreshness check at a glance – OnVu™ time-t t i di t h l t d hill h iCiba Specialty Chemicals Corp. is a
leading global company dedicated to producing high-value effects for its customers’ products. Joint development product: novel printable &
chargeable time temperature indicator
temperature indicators show accumulated chill-chain history of perishables
March 201228
chargeable time temperature indicator
Slide Approved by Companies or Information is Public Domain28
Software/Healthcare
P j t titl
Joint development product:
MediViz Systems- Medical IT software company developing
Project title:Operating Room Decision Support Center (ORDSC) Joint development product:Highly reliable operational data collectionsolution for the perioperative environment, supplying decision support tools
decision support solutions within high acuity care environments
problem identification,
Cedars Sinai Medical Center
p ,assignment, tracking andresolution assurance.
Cedars-Sinai Medical Center-serves the greater LA area; highly ranked nationally; promotes and markets use of advanced technology
March 201229
to deliver the highest quality of medical care
Slide Approved by Companies or Information is Public Domain
Molecular Imaging
Project title: Real time visualization of
Aposense Ltd. is a clinical stage molecular imaging and drug development
Project title: Real-time visualization of apoptosis within solid tumors
molecular imaging and drug development company, with a pipeline of products based on its patented platform technology for targeting apoptosis (programmed cell death) in vivo
Joint development product: Synthesis of radio-isotope labeled apoptosis marker and subsequent clinical studies
IBA Molecular North America is a leading global provider of PET radiopharmaceuticals
subsequent clinical studies. The usage of the labeled marker will enable real time visualization of efficacy of anti tumor treatment and will provide improved time and spatial resolution.
Slide Approved by Companies or Information is Public Domain March 201230
Bionic Eye
Project title: : Nano Retina
Rainbow Medical: is a medical devices innovation house, already responsible for
Project title: : Nano Retina
innovation house, already responsible for the successful launching of design and implementation of numerous medical devices.
Joint development product: A nanotechnology approach for sight
t ti b d A tifi i l R tiZyvex Labs exploits its predecessor company Zyvex Corporation’s technology for Micro-Electro-Mechanical-Systems (MEMS) microfabrication and 3D
restoration based on an Artificial Retina which interfaces electrodes with living retinal cells (neurons)
Slide Approved by Companies or Information is Public Domain
microassembly.
March 201231
Life Sciences - Pharma
Kamada specializes in the manufacture of therapeutic
Project title: Development of the API Manufacturing Process
pharmaceuticals from human plasma, using chromatographic separation techniques.
GLASSIATM
The American Red Cross (ARC) Joint Development:The project is to develop scale-up
GLASSIATM
( )collects ~6 million units of whole blood per year. One million liters of human plasma are derived to be manufactured into a variety of therapeutic plasma
The project is to develop, scale-up, manufacture and market API (Alpha-1-Proteinase Inhibitor), which is a protein synthesized in the liver and secreted into serum
Slide Approved by Companies or Information is Public Domain32
into a variety of therapeutic plasma protein pharmaceuticals.
serum.
March 2012
Life Sciences - Pharma
Project title: Novel therapeutics for
Atox Bio, Ltd. develops therapeutics for treatment of severe sepsis, septic
Project title: Novel therapeutics for severe sepsis and septic shock
p pshock and toxic shock.
Fast-Track Drugs and Biologics, LLC. g g ,is a contract research organization (CRO)
providing strategic planning, clinical trial and regulatory support services to the pharmaceutical and biotech industries for
Joint development product: pre-clinical and phase I studies in collaboration with the University of Maryland.
4/3/201233
pharmaceutical and biotech industries for the development and licensure of vaccines and therapeutics for human diseases.
Neurotechnology Seminar in Washington D CWashington, D.C.
Save the Date!
”Israel Neuroscience & Neurotechnology Collaborations‐Accelerating U.S.“ Israel Neuroscience & Neurotechnology CollaborationsAccelerating U.S.
Wednesday, September 12, 2012 - 8:30 am - 5:00 pmNational Academy of Sciences - 500 5th St. NW Washington, D.C.
The human brain is the most complex object of study in the history of science Brain research is affecting the life of all of us at any time.
The US-Israel conference will bring together researchers and companies from both countries to discuss their collaboration in investigating and understandingboth countries to discuss their collaboration in investigating and understanding
the function of the brain and showcase novel technologies that lead to new breakthroughs in the diagnosis and treatment of neurological disorders.